CareCloud, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by CareCloud, Inc. (CCLD) on November 26, 2025, regarding events occurring on November 24, 2025. The filing addresses the passing of an independent director and the resulting temporary non-compliance with Nasdaq listing standards.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing status events.
Material Changes
- Director Departure: Mr. John N. Daly, an independent director since July 2014, passed away on November 24, 2025. He served on the Audit Committee and chaired the Compensation Committee.
- Listing Non-Compliance: The Company notified Nasdaq that it no longer complies with Listing Rule 5605(b)(1) (majority of the Board must be independent) and Rule 5605(c)(2)(A) (Audit Committee must have at least three members).
Outlook, Risks, and Management Commentary
Nasdaq granted the Company a cure period to regain compliance, expiring on the earlier of the next annual meeting of shareholders or November 24, 2026. Management plans to appoint an additional independent director to fill the vacancy on the Audit Committee at the earliest opportunity. The filing does not disclose other material risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the timeline for the appointment of a new independent director to restore Audit Committee quorum.
- Monitor the Company's progress in regaining full compliance with Nasdaq Listing Rule 5605(b)(1) regarding the majority independent Board requirement.
- Confirm the date of the next annual meeting of shareholders, as this may impact the cure period deadline.